Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2022 · View financials
Decision snapshot: INFN stock price vs CTXR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CTXR's multiple
Needs CTXR P/S.
Implied fair value · at INFN's multiple
Needs INFN P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INFN FY 2024 (ended Dec 28, 2024) · CTXR FY 2022 (ended Sep 30, 2022). Fiscal years are not aligned.
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Infinera Corp · implied price per share
Bear
-$4.72
Base
-$5.55
Bull
-$6.39
Citius Pharmaceuticals, Inc. · implied price per share
Bear
$0.09
Base
$0.11
Bull
$0.13
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
5.74x
0.01x
Net debt / EBITDA
Leverage against operating earnings
-40.46x
0.09x
Cash and equivalents
Liquid reserves on the balance sheet
$172.32M
$4.25M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CIENA CORP
INFN vs CIEN
VIAVI SOLUTIONS INC.
INFN vs VIAV
JUNIPER NETWORKS INC
INFN vs JNPR
CISCO SYSTEMS, INC.
INFN vs CSCO
Arista Networks, Inc.
INFN vs ANET
Motorola Solutions, Inc.
INFN vs MSI
Zomedica Corp.
INFN vs ZOM
Aquestive Therapeutics, Inc.
INFN vs AQST
ACADIA PHARMACEUTICALS INC
INFN vs ACAD
AMGEN INC
INFN vs AMGN
GILEAD SCIENCES, INC.
INFN vs GILD
AbbVie Inc.
INFN vs ABBV
$668.41M
$1.00M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
